U.S. Securities and Exchange Commission Archives

Medtronic is holding its 2023 annual meeting of shareholders on Thursday, Oct. 19, 2023.

The world’s largest medical device company moved the date up from December for the first time since Medtronic relocated its Fridley, Minnesota headquarters to Ireland in 2015.

The company’s last annual meeting in Minnesota was in August 2014 at its Mounds View campus. Ever since then, Medtronic has held its annual meeting sometime during the first two weeks of December in Dublin, Ireland.

Related: 5 growth areas where Medtronic’s CEO wants to invest more

The earlier annual meeting date means any shareholders that want to nominate directors or submit any other proposal will need to do so in writing between July 21 and Aug. 30, Medtronic told investors in a filing with the U.S. Securities and Exchange Commission.

Those proposals will not be included in the proxy materials prepared for the annual meeting; the deadline for inclusion in proxy mat…

Medtronic has filed trademark applications for this Mozarc logo. [Image via the U.S. Patent and Trademark Office]Clues are pointing to Mozarc Medical as the name of the new kidney care company that Medtronic (NYSE:MDT) and DaVita (NYSE:DVA) are expected to launch this year.

The companies used “NewCo” as a placeholder when announcing the new company last year and said a renaming and rebranding would come when the deal closes sometime in 2023.

Since then, Medtronic has filed trademark applications with the U.S. Patent and Trademark Office for Mozarc and Mozarc Medical relating to dialysis products.

Medtronic listed itself as the applicant on five applications filed in August and December. Four more recent applications, filed in January, list Mozarc Medical US LLC as the applicant. All list the same attorney of record and the address of Medtronic’s Fridley, Minnesota headquarters.

Meanwhile, law firm DLA Piper — which represents Medtro…

U.S. Securities and Exchange Commission

Medtronic moves its 2023 annual meeting up for first time since HQ move

Medtronic and DaVita’s dialysis venture appears to be called Mozarc Medical
Regulatory filings indicate a medtech CEO is involved in the new kidney care company.